VIX
40
5
HD
10
-3
EFX
27
-2
PPG
48
-5
EBAY
54
-5
ZTS
31
-7
MHK
34
4
T
33
-5
CAG
31
-3
C
62
-2
HRL
3
-3
EQR
22
-2
AIV
31
-2
EA
42
-2
DD
42
-2
GIS
31
-3
NOV
53
-2
SPG
30
-2
MU
64
-2
DLTR
47
-4
VIX
40
5
HD
10
-3
EFX
27
-2
PPG
48
-5
EBAY
54
-5
ZTS
31
-7
MHK
34
4
T
33
-5
CAG
31
-3
C
62
-2
HRL
3
-3
EQR
22
-2
AIV
31
-2
EA
42
-2
DD
42
-2
GIS
31
-3
NOV
53
-2
SPG
30
-2
MU
64
-2
DLTR
47
-4
Financhill
Back

Enliven Therapeutics, Inc. 10K Form

Sell
40

ELVN
Enliven Therapeutics, Inc.

Last Price:
$43.73
Seasonality Move:
9.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ELVN News And Ratings

See the #1 stock for the next 7 days that we like better than ELVN

ELVN Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-15.8M
Price / Cash Flow: 0
Annual Sales: $7.73
Price / Book: 6.23

Profitability

EPS (TTM): -1.85790
Net Income (TTM): $-103.7M
Gross Margin: $-263K
Return on Equity: -25.64%
Return on Assets: -24.7%

Enliven Therapeutics, Inc. Earnings Forecast

Key Enliven Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 9 years have been positive in 4 years.

Enliven Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ELVN
Website: enliventherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 28.66
Quick Ratio: 27.92

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ELVN Technical Analysis vs Fundamental Analysis

Sell
40
Enliven Therapeutics, Inc. (ELVN) is a Sell

Is Enliven Therapeutics, Inc. a Buy or a Sell?